GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Amin Pharmaceutical Co (XTEH:AMIN1) » Definitions » Gross Profit

Amin Pharmaceutical Co (XTEH:AMIN1) Gross Profit : IRR0.00 Mil (TTM As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Amin Pharmaceutical Co Gross Profit?

Amin Pharmaceutical Co's gross profit for the six months ended in . 20 was IRR0.00 Mil. Amin Pharmaceutical Co's gross profit for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Amin Pharmaceutical Co's gross profit for the six months ended in . 20 was IRR0.00 Mil. Amin Pharmaceutical Co's Revenue for the six months ended in . 20 was IRR0.00 Mil. Therefore, Amin Pharmaceutical Co's Gross Margin % for the quarter that ended in . 20 was N/A%.

Amin Pharmaceutical Co had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Amin Pharmaceutical Co Gross Profit Historical Data

The historical data trend for Amin Pharmaceutical Co's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Amin Pharmaceutical Co Gross Profit Chart

Amin Pharmaceutical Co Annual Data
Trend
Gross Profit

Amin Pharmaceutical Co Semi-Annual Data
Gross Profit

Competitive Comparison of Amin Pharmaceutical Co's Gross Profit

For the Drug Manufacturers - Specialty & Generic subindustry, Amin Pharmaceutical Co's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Amin Pharmaceutical Co's Gross Profit Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amin Pharmaceutical Co's Gross Profit distribution charts can be found below:

* The bar in red indicates where Amin Pharmaceutical Co's Gross Profit falls into.



Amin Pharmaceutical Co Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Amin Pharmaceutical Co's Gross Profit for the fiscal year that ended in . 20 is calculated as

Gross Profit (A: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

Amin Pharmaceutical Co's Gross Profit for the quarter that ended in . 20 is calculated as

Gross Profit (Q: . 20 )=Revenue - Cost of Goods Sold
= -
=0.00

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Gross Profit for the trailing twelve months (TTM) ended in . 20 was IRR0.00 Mil.

Gross Profit is the numerator in the calculation of Gross Margin. (Note that if there's no value for Cost of Goods Sold, then Gross Margin % is not calculated.)

Amin Pharmaceutical Co's Gross Margin % for the quarter that ended in . 20 is calculated as

Gross Margin % (Q: . 20 )=Gross Profit (Q: . 20 ) / Revenue (Q: . 20 )
=(Revenue - Cost of Goods Sold) / Revenue
=0.00 /
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Amin Pharmaceutical Co  (XTEH:AMIN1) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Amin Pharmaceutical Co had a gross margin of N/A% for the quarter that ended in . 20 => No sustainable competitive advantage


Amin Pharmaceutical Co Gross Profit Related Terms

Thank you for viewing the detailed overview of Amin Pharmaceutical Co's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Amin Pharmaceutical Co (XTEH:AMIN1) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.

Amin Pharmaceutical Co (XTEH:AMIN1) Headlines

No Headlines